Bisphosphonate Treatment of Bone Disease

Overview

Journal Arch Dis Child

Specialty Pediatrics

Date 2005 Apr 27

PMID 15851432

Citations 23

Authors

N J Shaw

N J Bishop

Affiliations

Soon will be listed here.

Abstract

In 1997 a review article on bisphosphonates in this journal identified 24 published articles relating to children at that time. Since then there has been a considerable increase in their use in clinical paediatric practice and research with there being nearly a further one hundred articles published at the time of writing.

Citing Articles

Cationic Hydroxyethyl Cellulose Nanocomplexes and RANK siRNA/Zoledronate Co-Delivery Systems for Osteoclast Inhibition.

Lee S, Park S, Kim T Pharmaceutics. 2025; 16(12.

PMID: 39771601 PMC: 11679713. DOI: 10.3390/pharmaceutics16121623.

Clinical spectrum of rare bone fragility disorders and response to bisphosphonate treatment: a retrospective study.

Charpie M, Brunelle P, Baujat G, Michot C, Van Gils J, Leheup B Eur J Hum Genet. 2024; 32(12):1559-1566.

PMID: 38926541 PMC: 11607398. DOI: 10.1038/s41431-024-01645-4.

Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers.

Anwar S, Yokota T Genes (Basel). 2023; 14(12).

PMID: 38136984 PMC: 10742611. DOI: 10.3390/genes14122162.

Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications.

Bahk J, Jo W, Kwon S, Park H, Lim Y J Clin Med. 2023; 12(4).

PMID: 36836169 PMC: 9961848. DOI: 10.3390/jcm12041637.

Abnormalities in Tooth Formation after Early Bisphosphonate Treatment in Children with Osteogenesis Imperfecta.

Malmgren B, Thesleff I, Dahllof G, Astrom E, Tsilingaridis G Calcif Tissue Int. 2021; 109(2):121-131.

PMID: 33743023 PMC: 8273054. DOI: 10.1007/s00223-021-00835-2.

References

Zacharin M, Bateman J . Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response. J Pediatr Endocrinol Metab. 2002; 15(2):163-74. DOI: 10.1515/jpem.2002.15.2.163. View

Attard T, Dhawan A, Kaufman S, Collier D, Langnas A . Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation. Pediatr Transplant. 1999; 2(2):157-9. View

Kanumakala S, Boneh A, Zacharin M . Pamidronate treatment improves bone mineral density in children with Menkes disease. J Inherit Metab Dis. 2002; 25(5):391-8. DOI: 10.1023/a:1020103901969. View

Henderson R, Lark R, Kecskemethy H, Miller F, Harcke H, Bachrach S . Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr. 2002; 141(5):644-51. DOI: 10.1067/mpd.2002.128207. View

Rauch F, Travers R, Plotkin H, Glorieux F . The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest. 2002; 110(9):1293-9. PMC: 151613. DOI: 10.1172/JCI15952. View

Bielinski B, Darbyshire P, Mathers L, Crabtree N, Kirk J, Stirling H . Impact of disordered puberty on bone density in beta-thalassaemia major. Br J Haematol. 2003; 120(2):353-8. DOI: 10.1046/j.1365-2141.2003.04066.x. View

Batch J, Couper J, Rodda C, Cowell C, Zacharin M . Use of bisphosphonate therapy for osteoporosis in childhood and adolescence. J Paediatr Child Health. 2003; 39(2):88-92. DOI: 10.1046/j.1440-1754.2003.00083.x. View

Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux F . Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab. 2003; 88(3):986-92. DOI: 10.1210/jc.2002-021371. View

Rauch F, Plotkin H, Zeitlin L, Glorieux F . Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy. J Bone Miner Res. 2003; 18(4):610-4. DOI: 10.1359/jbmr.2003.18.4.610. View

10.

Rosen C, Brown S . Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med. 2003; 348(15):1503-4. DOI: 10.1056/NEJM200304103481521. View

11.

Steelman J, Zeitler P . Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J Pediatr. 2003; 142(4):417-23. DOI: 10.1067/mpd.2003.137. View

12.

Montpetit K, Plotkin H, Rauch F, Bilodeau N, Cloutier S, Rabzel M . Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta. Pediatrics. 2003; 111(5 Pt 1):e601-3. DOI: 10.1542/peds.111.5.e601. View

13.

Noguera A, Ros J, Pavia C, Alcover E, Valls C, Villaronga M . Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. J Pediatr Endocrinol Metab. 2003; 16(4):529-36. DOI: 10.1515/jpem.2003.16.4.529. View

14.

Whyte M, Wenkert D, Clements K, McAlister W, Mumm S . Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003; 349(5):457-63. DOI: 10.1056/NEJMoa023110. View

15.

Fewtrell M . Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls. Arch Dis Child. 2003; 88(9):795-8. PMC: 1719622. DOI: 10.1136/adc.88.9.795. View

16.

Hosking D, Adami S, Felsenberg D, Andia J, Valimaki M, Benhamou L . Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. Curr Med Res Opin. 2003; 19(5):383-94. DOI: 10.1185/030079903125002009. View

17.

Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux F . Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab. 2003; 88(10):4569-75. DOI: 10.1210/jc.2003-030050. View

18.

Peter R, Mishra V, Fraser W . Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ. 2004; 328(7435):335-6. PMC: 338107. DOI: 10.1136/bmj.328.7435.335. View

19.

Cundy T, Wheadon L, King A . Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy. J Bone Miner Res. 2004; 19(5):703-11. DOI: 10.1359/JBMR.040127. View

20.

Rauch F, Glorieux F . Osteogenesis imperfecta. Lancet. 2004; 363(9418):1377-85. DOI: 10.1016/S0140-6736(04)16051-0. View